Home > M&A deals 2011 > The Riverside Company and Oquendo Capital acquire Orliman, S.L.
Buyout (LBO, MBO, MBI) · Medical Products · January 2011

The Riverside Company and Oquendo Capital acquire Orliman, S.L.

On January 26, 2011, The Riverside Company and Oquendo Capital acquired Orliman, S.L., a medical products company in Spain.

Deal at a glance

AnnouncedJanuary 26, 2011 TypeBuyout (LBO, MBO, MBI) TargetOrliman, S.L. Buyers The Riverside Company
Oquendo Capital SectorMedical Products LocationSpain ValueMembers only

Target company

Orliman, S.L.
Spain
Medical Productssector
1967founded
Activestatus
View the company profile →

Buyers (2)

The Riverside Company Lead
Private equity firm · 308 deals on record
Oquendo Capital Co-investor
Private equity firm · 16 deals on record
  • 14th transaction for the lead buyer in medical products
  • 2nd transaction in Spain
308deals, all time
17in this sector
2022latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Healthcare Operations SolutionsSame lead buyer · May 2022
Centium SoftwareSame lead buyer · Mar 2022
Esha Research, Inc.Same lead buyer · Feb 2022
AKRN Scientific Consulting S.L.Same sector and country · Mar 2022

Questions about this deal

Who acquired Orliman, S.L.?The Riverside Company and Oquendo Capital acquired Orliman, S.L. on January 26, 2011.

What type of deal was it?It was a buyout (lbo, mbo, mbi) in the medical products sector in 2011.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).